Johnson & Johnson COVID-19 vaccine production error has no impact on doses distributed, White House says



The production error that occurred at Emergent BioSolutions and saw millions of Johnson & Johnson COVID-19 vaccines discarded does not impact the doses already distributed, the White House said on Friday. Jeff Zients, the White House coronavirus response coordinator, said all doses of the Johnson & Johnson vaccine already distributed in the United States came from another FDA-approved facility.

Zients said the FDA is currently working with Johnson & Johnson to further investigate the issue, and will provide and update when the probe is complete.

Workers at the Baltimore production plant have reportedly mixed ingredients from the Johnson & Johnson vaccine with those from the AstraZeneca vaccine, which has yet to be approved. The Associated Press on Thursday revealed that Emerging BioSolutions had a history of citations from the FDA for issues involving poorly trained employees, cracked vials and mold at one of its facilities.

FDA MODERNA EUA UPDATE TO ACCELERATE MOVEMENT

Johnson & Johnson delivered 20 million doses at the end of March and has committed to deliver an additional 24 million by April.

“More importantly, the company is committed to reaching or nearly 100 million doses by the end of May,” Zients said. “Looking back, we’ll have enough supply for all Americans by the end of May, which is most important here,” Zients said.

CAN I STILL SPREAD CORONAVIRUS AFTER I HAVE VACCINATED?

In an update on the nation’s immunization effort, Zients said the United States is administering an average of 2.7 million vaccines per day, up from 2.5 million last week.

CLICK HERE FOR FULL CORONAVIRUS COVERAGE

“No other country has vaccinated so many people so quickly,” he said.


Source link